Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Free Cash Flow (2020 - 2025)

Historic Free Cash Flow for Roivant Sciences (ROIV) over the last 6 years, with Q4 2025 value amounting to -$191.5 million.

  • Roivant Sciences' Free Cash Flow rose 7143.93% to -$191.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$593.5 million, marking a year-over-year increase of 4758.5%. This contributed to the annual value of -$844.0 million for FY2025, which is 1009.59% down from last year.
  • As of Q4 2025, Roivant Sciences' Free Cash Flow stood at -$191.5 million, which was up 7143.93% from -$193.5 million recorded in Q3 2025.
  • Roivant Sciences' Free Cash Flow's 5-year high stood at -$123.4 million during Q3 2021, with a 5-year trough of -$675.4 million in Q4 2022.
  • Moreover, its 5-year median value for Free Cash Flow was -$208.4 million (2025), whereas its average is -$317.8 million.
  • As far as peak fluctuations go, Roivant Sciences' Free Cash Flow crashed by 19926.49% in 2021, and later soared by 7143.93% in 2025.
  • Over the past 5 years, Roivant Sciences' Free Cash Flow (Quarter) stood at -$541.4 million in 2021, then decreased by 24.74% to -$675.4 million in 2022, then grew by 2.6% to -$657.8 million in 2023, then fell by 1.95% to -$670.7 million in 2024, then soared by 71.44% to -$191.5 million in 2025.
  • Its Free Cash Flow was -$191.5 million in Q4 2025, compared to -$193.5 million in Q3 2025 and -$208.4 million in Q2 2025.